NetScientific PLC (LON:NSCI) has said its portfolio company, Wanda Health, is expanding into orthopaedics through a new partnership with HRS Home Health (HRS).
The AIM-listed healthcare IP commercialisation group said the partnership would bring Wanda’s specialities in predictive analytics and artificial intelligence (AI) to bear on orthopaedics.
READ: NetScientific says portfolio company Vortex signs partnership deal with cell imaging firm BioView
The company added that initial pilot studies had demonstrated a decrease in the length of time patients were required to remain in hospital through the use of Wanda’s technology by HRS.
NetScientific also said that through the new partnership with HRS, Wanda’s Telehealth and Predictive Analytics would provide real-time data and informatics to orthopaedic surgeons and their clinical teams.
The company added that initial pilot results had demonstrated an 18% decrease in cost per case compared to cases not in the pilot. Length of stay for pilot cases also decreased to 11.5 days from 19.4 days while patients achieved desired outcomes 41% quicker than prior to the pilot.
NetScientific’s chief executive and chairman of Wanda, Francois R. Martelet, said: "We are delighted to announce that Wanda is expanding its analytical focus to orthopaedics, which demonstrates the flexibility and potential of the technology. In particular, we are pleased that the initial pilot cases demonstrate a decrease in length of stay (LOS) from 19.4 days to 11.5 days, achieving desired outcomes for patients 41% quicker when using Wanda technology."
NetScientific currently holds a 61.8% stake on a fully diluted basis in Wanda.